New Book Shows Billions are Being Wasted on Statins

LONDON - Millions of people already take a statin to lower their cholesterol and
millions more are about to be prescribed these drugs under current
guidelines. However, a new book provides substantial evidence to show that
most people do not need to lower their cholesterol.

Using official statistics and references from medical literature, the
author makes a strong case against the mass prescription of
cholesterol-lowering drugs. The key findings in the book are:

- What is being suggested as ‘high’ cholesterol is in many cases simply a
normal or average cholesterol level

- Most people who have a heart attack do not have high
cholesterol - their cholesterol tends to be average or below the
average for the general population

- Higher cholesterol does not correlate with a higher incidence
of heart disease when we look at most countries around the world

- The rate of heart disease continues to increase despite large
reductions in the number of people with ‘high’ cholesterol

- The average cholesterol level for people in the UK is low
when compared with the rest of Europe. Despite this, the UK has one of
the highest rates of heart attacks

- The latest research has completely changed our understanding
of heart disease and has led many researchers to abandon the idea that
the arteries simply get clogged-up with fats

- Foods that have been designed specifically to lower cholesterol have
adverse effects that have not been communicated to consumers

The author describes how problems within medical research have allowed a
general fear of cholesterol to develop and how the results from statin trials
have been routinely exaggerated to imply greater benefits than were actually
achieved.

The millions of people facing the decision of whether or not to take a
statin will find the information in this book essential.

This is the first book on the subject that is genuinely accessible to the
general reader; the new findings and scientific references will also be of
use to those with a professional interest.

The author estimates the global cholesterol-lowering industry to be worth
$29 billion and calls for a new approach to the prevention of heart disease.

Title: $29 Billion Reasons to Lie about Cholesterol: Making Profit by
Turning Healthy People into Patients. By Justin Smith

ISBN: 9781848760714
Price GBP9.99

Contact:
Justin Smith
www.29billion.com
info@29billion.com
Phone +44(0)7817485038

Source: Citifit Wellness Services Ltd

Contact: Justin Smith, info at 29billion.com, Phone +44(0)7817485038